Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology; D000662:Amphetamines; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D002928:Cinanserin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006120:Grooming / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D011954:Receptors, Dopamine / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*; D013237:Stereoisomerism
D000662:Amphetamines; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; C003943:2,5-dimethoxy-4-bromoamphetamine; D006220:Haloperidol; D002928:Cinanserin